MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Income Overview
Net Income
-$22,285K
EPS
-$1.18
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
Research and development
18,048
-
-21,204*
General and administrative
6,170
-
5,137*
Total operating expenses
24,218
-
-16,067
Research and development expense-Employee Related Expenses
-
-4,119
-
Loss from operations
-24,218
-
16,067*
General and administrative expense-Employee Related Expenses
-
-1,755
-
Interest income
2,021
-
2,825*
Research and development expense-Research And Pre-Clinical Expenses
-
-1,578
-
Interest expense
6
-
16*
Research and development expense-Clinical And Development Expenses
-
-9,664
-
Change in fair value of safe liabilities
-
-
0*
Research and development expense-Chemistry Manufacturing And Control Expenses
-
-3,518
-
Other expense
-5
-
-30*
Research and development expense-Non-Clinical Science Expenses
-
-314
-
Total other income, net
2,010
-
2,779*
Non-controllable expenses
-
-2,822
-
Loss before income tax
-22,208
-
18,846*
Other income
-
-1,471
-
Income tax expense
77
-
308*
Net loss
-22,285
-25,241
18,538
Basic EPS
-1.18
-1.34
-1.012
Diluted EPS
-1.18
-1.34
-1.012
Basic Average Shares
18,964,008
18,769,004
18,322,533
Diluted Average Shares
18,964,008
18,769,004
18,322,533
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
TECX Income Statement Sankey Diagram
Sankey diagram visualizing TECX income statement for the period
Net loss
-$22,285K
Interest income
$2,021K
Loss before income
tax
-$22,208K
Income tax expense
$77K
Total other income,
net
$2,010K
Interest expense
$6K
Other expense
-$5K
Loss from operations
-$24,218K
Total operating
expenses
$24,218K
Research and development
$18,048K
General and
administrative
$6,170K
Buy us a coffee
Tectonic Therapeutic, Inc. (TECX)
Tectonic Therapeutic, Inc. (TECX)